Business Description
Akso Health Group
SIC : 6141
ISIN : US4282951098
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 26.32 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.27 | |||||
Beneish M-Score | 0.28 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.7 | |||||
3-Year EBITDA Growth Rate | 40.6 | |||||
3-Year EPS without NRI Growth Rate | 27.3 | |||||
3-Year FCF Growth Rate | 66 | |||||
3-Year Book Growth Rate | -49.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.68 | |||||
9-Day RSI | 39.71 | |||||
14-Day RSI | 39.93 | |||||
6-1 Month Momentum % | -7.41 | |||||
12-1 Month Momentum % | 306.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.46 | |||||
Quick Ratio | 1.36 | |||||
Cash Ratio | 0.8 | |||||
Days Inventory | 227.86 | |||||
Days Sales Outstanding | 1176.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 8.21 | |||||
Operating Margin % | -737.74 | |||||
Net Margin % | -253.74 | |||||
FCF Margin % | -75.42 | |||||
ROE % | -70.76 | |||||
ROA % | -28.99 | |||||
ROIC % | -1879.77 | |||||
ROC (Joel Greenblatt) % | -33323.08 | |||||
ROCE % | -188.73 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.04 | |||||
PB Ratio | 3.42 | |||||
Price-to-Tangible-Book | 3.38 | |||||
EV-to-EBIT | -5.05 | |||||
EV-to-EBITDA | -5.05 | |||||
EV-to-Revenue | 34.54 | |||||
EV-to-FCF | -45.69 | |||||
Price-to-Projected-FCF | 0.34 | |||||
Price-to-Net-Current-Asset-Value | 3.38 | |||||
Earnings Yield (Greenblatt) % | -19.8 | |||||
FCF Yield % | -1.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Akso Health Group Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 2.075 | ||
EPS (TTM) (€) | -0.225 | ||
Beta | -2.1 | ||
Volatility % | 325.01 | ||
14-Day RSI | 39.93 | ||
14-Day ATR (€) | 0.063885 | ||
20-Day SMA (€) | 0.83475 | ||
12-1 Month Momentum % | 306.5 | ||
52-Week Range (€) | 0.188 - 2.54 | ||
Shares Outstanding (Mil) | 109.58 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Akso Health Group Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Akso Health Group Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Akso Health Group Frequently Asked Questions
What is Akso Health Group(FRA:8HX)'s stock price today?
When is next earnings date of Akso Health Group(FRA:8HX)?
Does Akso Health Group(FRA:8HX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |